fda glp-1 compounding crackdown october 2025 issued 25 warning letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA CRACKDOWN ESCALATES: 30 telehealth

This could help treat many medical conditions

We examine the statutory friction between the Drug Quality and Security Act (DQSA) and the Patent Act, the weaponization of the essentially a copy doctrine, and the strategic litigation currently reshaping the market

and the addition of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to the insulin therapy, which can be administered via subcutaneous injection once or twice daily, or weekly depending on formulation

Supplementing with it during a CJC1295 cycle can help maintain optimal hormone balance, especially in older adults or those with lower natural androgen production